BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Coronavirus updates'. (Return)

CNBC BusinessApr 10, 2020
Coronavirus live updates: South Korea reports 27 new cases; outbreak at Chicago's largest jail
The city of Daegu, which was South Korea's epicenter and had huge spikes in cases during the thick of the pandemic, reported no new cases.

RELATED ARTICLES
Coronavirus Updates: Jobless Claims Surpass 16 Million; Aid Package Stalls in Senate (NYTimes Business)

NYTimes BusinessApr 10, 2020
OPEC Talks to Cut Oil Production Disappoint Traders
Live updates on stock market and business news during the coronavirus outbreak.

Yahoo BusinessApr 09, 2020
Stock market news live updates: Stocks rally, S&P posts best week in 46 years after Fed rides to the rescue with new stimulus
Stocks cut earlier losses from the overnight session and opened higher Thursday after the Federal Reserve unexpectedly unleashed a new multi-trillion-dollar stimulus plan to support businesses during the coronavirus pandemic.


Yahoo BusinessApr 09, 2020
Edited Transcript of UAL earnings conference call or presentation 17-Apr-19 2:30pm GMT
The enormity of the coronavirus pandemic has forced biopharma companies to step up efforts to expeditiously develop vaccines and treatments for COVID-19. The Frontrunners Moderna Inc (NASDAQ: MRNA), which was the first company to move its coronavirus vaccine candidate to the clinics, said in mid-March that the first participant has been dosed in an NIH-led, Phase 1 study of its mRNA vaccine in the U.S.Inovio Pharmaceuticals Inc (NASDAQ: INO) announced earlier this week that it is initiating a Phase 1 study to test its DNA vaccine for the coronavirus following the FDA's acceptance of Inovio's IND application.Apart from these companies, CanSino Biologics and the Academy of Military Sciences are running Phase 1 trials of their non-replicating vaccine candidate in China.The University of Oxford is testing a chimpanzee adeno vector vaccine candidate in a Phase 1/2 trial in the U.K.Novavax, Inc. (NASDAQ: NVAX) said Wednesday it has identified a vaccine candidate and is planning to initiate human trials in mid-May.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.See also: How The COVID-19 Outbreak Is Benefiting Biotech Investors Pfizer, BioNTech Make Progress Pfizer Inc. (NYSE: PFE) and BioNTech SE - ADR (NASDAQ: BNTX), which initially announced a collaboration to develop a COVID-19 vaccine on March 17, released further details on the
TRENDING TAGS
Coronaviruslive York updates cases UPDATE
COVID-19million During amid Help Business
oilOPEC Cut deal Russia Saudi
FedTrillion Market economy support Dow
Liveupdates Coronavirus Stock Fed market
MillionClaims Coronavirus Jobless unemployment OPEC
cutOil OPEC Russia Production deal
StockMarket Fed stimulus Today coronavirus
EconomyFed coronavirus could trillion support
OPECOil Cut Production cuts prices

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC